GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins February 19, 2025
Displaying entries 23151 - 23200 of 41249 in total
PDB ID UniProt ID Title ▲ Descriptor
2XEG Q04609 Human glutamate carboxypeptidase II in complex with Antibody- Recruiting Molecule ARM-P4
2XEF Q04609 Human glutamate carboxypeptidase II in complex with Antibody- Recruiting Molecule ARM-P8
3CEJ P06737 Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE2865 Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE2865
3CEM P06737 Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE9423 Glycogen phosphorylase (E.C.2.4.1.1)
8CVX P13807 Human glycogenin-1 and glycogen synthase-1 complex in the presence of glucose-6-phosphate
8CVX P46976 Human glycogenin-1 and glycogen synthase-1 complex in the presence of glucose-6-phosphate
5ZHO Q82040 Human group C rotavirus VP8*s recognize type A histo-blood group antigens as ligands
4X0L P69905 Human haptoglobin-haemoglobin complex
4X0L P68871 Human haptoglobin-haemoglobin complex
4X0L P00738 Human haptoglobin-haemoglobin complex
7ZAY Q16394 Human heparan sulfate polymerase complex EXT1-EXT2
7ZAY Q93063 Human heparan sulfate polymerase complex EXT1-EXT2
8CQI Q9Y251 Human heparanase in complex with inhibitor R3794
7B7N P29317 Human herpesvirus-8 gH/gL in complex with EphA2
7B7N Q98142 Human herpesvirus-8 gH/gL in complex with EphA2
7B7N Q76RG7 Human herpesvirus-8 gH/gL in complex with EphA2
8ZQO Q9GZV3 Human high-affinity choline transporter CHT1 bound to HC-3 under NaCl condition, with sodium and chloride ions coordinated.
8ZQP Q9GZV3 Human high-affinity choline transporter CHT1 bound to ML352 under NaCl condition, with sodium ion coordinated.
8ZQQ Q9GZV3 Human high-affinity choline transporter CHT1 bound to choline under NaCl condition, with sodium and chloride ions coordinated.
8ZQR Q9GZV3 Human high-affinity choline transporter CHT1 in apo state under NaCl condition.
8J74 Q9GZV3 Human high-affinity choline transporter CHT1 in the HC-3-bound outward-facing open conformation, dimeric state
8J75 Q9GZV3 Human high-affinity choline transporter CHT1 in the HC-3-bound outward-facing open conformation, monomeric state
8J77 Q9GZV3 Human high-affinity choline transporter CHT1 in the choline-bound inward-facing occluded conformation
8J76 Q9GZV3 Human high-affinity choline transporter CHT1 in the inward-facing apo-open conformation
4MJ4 P35475 Human iduronidase apo structure P21 form
8ONI P01308 Human insulin in complex with the analytical antibody S1 Fab
8ONI 8ONI Human insulin in complex with the analytical antibody S1 Fab
6VEP P01308 Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7
6VEP 6VEP Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7
6VEP P06213 Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7
5J3H 5J3H Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv
5J3H P06213 Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv
5IUE B3KUD8 Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors
5IUE P61769 Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors
5IUE 5IUE Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors
5KNM B3KUD8 Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors
5KNM P61769 Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors
5KNM Q8NHL6 Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors
5KNM 5KNM Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors
3B29 Q16873 Human leukotriene C4 synthase in complex with dodecyl-beta-D-selenomaltoside
5Q0C O00757 Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(4-methoxyphenyl)thiophen-2-yl]sulfonylurea and with fructose-2,6-diphosphate
3CEH P06737 Human liver glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE5688 Glycogen phosphorylase (E.C.2.4.1.1)
1L5Q P06737 Human liver glycogen phosphorylase a complexed with caffeine, N-Acetyl-beta-D-glucopyranosylamine, and CP-403700 Glycogen phosphorylase, liver form (E.C.2.4.4.1)
2ZB2 P06737 Human liver glycogen phosphorylase a complexed with glcose and 5-chloro-N-[4-(1,2-dihydroxyethyl)phenyl]-1H-indole-2-carboxamide
1L5R P06737 Human liver glycogen phosphorylase a complexed with riboflavin, N-Acetyl-beta-D-Glucopyranosylamine and CP-403,700 glycogen phosphorylase, liver form (E.C.2.4.4.1)
1L7X P06737 Human liver glycogen phosphorylase b complexed with caffeine, N-acetyl-beta-D-glucopyranosylamine, and CP-403,700 Glycogen phosphorylase, liver form (E.C.2.4.1.1.)
1L5S P06737 Human liver glycogen phosphorylase complexed with uric acid, N-Acetyl-beta-D-glucopyranosylamine, and CP-403,700 Glycogen phosphorylase, liver form (E.C.2.4.4.1)
8W2I P17858 Human liver phosphofructokinase-1 filament in the R-state conformation
8W2J P17858 Human liver phosphofructokinase-1 filament in the T-state conformation
8W2G P17858 Human liver phosphofructokinase-1 in the R-state conformation

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.1

Last updated: February 17, 2025